Chargement en cours...
Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
The central importance of angiogenesis and our understanding of how new blood vessels are formed have led to the development of novel antiangiogenic therapies. Although the number of agents in development has grown exponentially, only one phase III trial in breast cancer has been completed. In that...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC400679/ https://ncbi.nlm.nih.gov/pubmed/15084233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr782 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|